Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 26, 2012
Almac is pleased to announce the successful inspection of its Clinical Services operations located in Craigavon by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
read more
Tuesday, September 25, 2012
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products, announced today the promotion of Rick Hancock to the position of President and CEO, Chris Duffy to Senior Vice President of ...
read more
Wednesday, September 19, 2012
Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and...
read more
Wednesday, September 19, 2012
Victor Vinci, Ph.D., has joined Cook Pharmica’s leadership team as vice president and chief scientific officer. Vinci will be responsible for guiding the scientific direction of Cook Pharmica, applying his more than 20 years of broad technical, ...
read more
Thursday, September 13, 2012
AIT Bioscience is pleased to announce that Dr.Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug ...
read more
CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, today announced that it has hired Patricio E. Massera to serve as the Company’s new General Manager for its ...
read more
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) has created the Pharmatek Foundation, a not-for-profit organization supporting volunteerism for causes in the San Diego community. The Foundation's ...
read more
Modality Solutions, LLC, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, has named Shubhra Kochar Consulting Engineer.
read more
United Drug plc, a leading international provider of healthcare services announces that it has reached agreement to acquire the UK and US clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited...
read more
Wednesday, August 08, 2012
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced the appointment of Bruce Kutinsky as its Chief Operating Officer of its US operations effective September 1, 2012. Mr. Kutinsky was most recently the President of ...
read more
Pharmaceutical Product Development, LLC (PPD) has earned the highest ratings in customer loyalty, overall value and several other attributes for Phase I services according to an Industry Standard Research (ISR) study, which evaluated 12 Phase I ...
read more
Boehringer Ingelheim announced today an agreement with Servier and its partner XOMA Corporation (Nasdaq: XOMA) to transfer XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta (IL-1ß) allosteric...
read more
PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne R. Larson has been appointed as Vice President, ...
read more
Cytovance® Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Don Wuchterl as the new Senior Vice President of Manufacturing Operations
read more
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of IGI Laboratories, Inc. effective July 30, 2012.
read more